NASDAQ: NMRA Neumora Therapeutics, Inc. 8-K

Neumora Therapeutics reports Q4 and full-year 2025 financial results

Filed March 30, 2026 · Period ending March 30, 2026 · ~1 min read

2 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade NMRA commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 4, 2026 1:57 AM